Literature DB >> 30190976

Liver transplantation for metastatic neuroendocrine tumors.

Louise Barbier1,1, Cindy Neuzillet2,2, Safi Dokmak1,1, Alain Sauvanet1,1, Philippe Ruszniewski3,3, Jacques Belghiti1,1.   

Abstract

Neuroendocrine tumors are a heterogeneous group of rare epithelial tumors. Most of them are metastatic at the time of initial diagnosis. Liver transplantation (LT) has been proposed in selected patients with diffuse liver involvement. Rationale for LT in this indication is based on the frequently indolent nature of neuroendocrine tumors, the propensity for liver-only metastasis and the high rate of intrahepatic recurrence after resection. However, indications for LT for neuroendocrine liver metastases remain controversial, and patient selection criteria is still a matter of debate. The aim of this review is to summarize data regarding LT for neuroendocrine liver metastases by answering frequently asked questions about this issue.

Entities:  

Keywords:  Ki-67 antigen; carcinoid tumor; liver transplantation; neuroendocrine tumor; survival

Year:  2014        PMID： 30190976      PMCID： PMC6095166          DOI： 10.2217/hep.14.21

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


  39 in total

1.  ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas.

Authors:  Ulrich-Frank Pape; Aurel Perren; Bruno Niederle; David Gross; Thomas Gress; Frederico Costa; Rudolf Arnold; Timm Denecke; Ursula Plöckinger; Ramon Salazar; Ashley Grossman
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

2.  ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Authors:  Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

3.  Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).

Authors:  René Adam; Vincent Karam; Valérie Delvart; John O'Grady; Darius Mirza; Jurgen Klempnauer; Denis Castaing; Peter Neuhaus; Neville Jamieson; Mauro Salizzoni; Stephen Pollard; Jan Lerut; Andreas Paul; Juan Carlos Garcia-Valdecasas; Fernando San Juan Rodríguez; Andrew Burroughs
Journal:  J Hepatol       Date:  2012-05-16       Impact factor: 25.083

4.  Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?

Authors:  Vincenzo Mazzaferro; Andrea Pulvirenti; Jorgelina Coppa
Journal:  J Hepatol       Date:  2007-07-26       Impact factor: 25.083

5.  The dedifferentiation of neuroendocrine tumor metastases: myth or reality?

Authors:  Cătălina Poiană; M C Neamţu; Elena Taina Avramescu; Mara Carşote; Raluca Trifănescu; Dana Terzea; Oana Maria Neamţu; Rucsandra Dănciulescu Miulescu
Journal:  Rom J Morphol Embryol       Date:  2013       Impact factor: 1.033

6.  Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.

Authors:  Jens Rosenau; Matthias J Bahr; Reinhard von Wasielewski; Michael Mengel; Hartmut H J Schmidt; Björn Nashan; Hauke Lang; Jürgen Klempnauer; Michael P Manns; Klaus H W Boeker
Journal:  Transplantation       Date:  2002-02-15       Impact factor: 4.939

Review 7.  Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis.

Authors:  Zoltan Máthé; Evangelos Tagkalos; Andreas Paul; Ernesto P Molmenti; László Kóbori; Ioannis Fouzas; Susanne Beckebaum; Georgios C Sotiropoulos
Journal:  Transplantation       Date:  2011-03-15       Impact factor: 4.939

Review 8.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 9.  Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.

Authors:  Skye C Mayo; Joseph M Herman; David Cosgrove; Nik Bhagat; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2012-10-11       Impact factor: 6.113

10.  Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.

Authors:  Frederike G I van Vilsteren; Edwina S Baskin-Bey; David M Nagorney; Schuyler O Sanderson; Walter K Kremers; Charles B Rosen; Gregory J Gores; Timothy J Hobday
Journal:  Liver Transpl       Date:  2006-03       Impact factor: 5.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.